Insulin resistance is a major aspect of type 2 diabetes (T2D), which results from impaired insulin signaling in target cells. Signaling to regulate forkhead box protein O1 (FOXO1) may be the most important mechanism for insulin to control transcription. Despite this, little is known about how insulin regulates FOXO1 and how FOXO1 may contribute to insulin resistance in adipocytes, which are the most critical cell type in the development of insulin resistance. We report a detailed mechanistic analysis of insulin control of FOXO1 in human adipocytes obtained from non-diabetic subjects and from patients with T2D. We show that FOXO1 is mainly phosphorylated through mTORC2-mediated phosphorylation of protein kinase B at Ser 473 and that this mechanism is unperturbed in T2D. We also demonstrate a cross-talk from the MAPK branch of insulin signaling to stimulate phosphorylation of FOXO1. The cellular abundance and consequently activity of FOXO1 are halved in T2D. Interestingly, inhibition of mTORC1 with rapamycin reduces the abundance of FOXO1 to the levels in T2D. This suggests that the reduction of the concentration of FOXO1 is a consequence of attenuation of mTORC1, which defines much of the diabetic state in human adipocytes. We integrate insulin control of FOXO1 in a network-wide mathematical model of insulin signaling dynamics based on compatible data from human adipocytes. The diabetic state is network-wide explained by attenuation of an mTORC1-to-insulin receptor substrate-1 (IRS1) feedback and reduced abundances of insulin receptor, GLUT4, AS160, ribosomal protein S6, and FOXO1. The model demonstrates that attenuation of the mTORC1-to-IRS1 feedback is a major mechanism of insulin resistance in the diabetic state.Insulin has a crucial function to maintain energy homeostasis at the whole-body level and at the cellular level in a variable environment of nutrient supply. Failure to sustain this function is at the center of diabetes. Type 2 diabetes (T2D) 2 is characterized by failure to properly respond to insulin in target cells (insulin resistance) and by impaired production of the hormone. Because of the central role of insulin in energy homeostasis, effects of insulin are pleiotropic, affecting almost every aspect of cellular metabolism, which is reflected in a highly branched signaling network in target cells of the hormone. T2D is also closely related to obesity (1), and the insulin resistance first develops in the adipocytes of an expanding adipose tissue. Failure to store fat in the adipose tissue then leads to ectopic fat deposition in other organs, such as liver and muscle, which is believed to spread the insulin resistance to those organs (2). Eventually the insulin-producing -cells often fail to compensate for the insulin resistance, and T2D can be diagnosed. It is therefore of primary importance to understand the disease mechanisms in human adipocytes to be able to treat the disease at an early stage before other organs are affected.Forkhead box protein O1 (FOXO1) may be the most important mediator o...